Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Natera, Inc. - Common Stock
(NQ:
NTRA
)
171.86
+0.88 (+0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Natera, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Reasons We Love Natera (NTRA)
June 20, 2025
Natera has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 5% to $170 per share while the index has gained 1.1%.
Via
StockStory
Topics
Government
Stocks
Exposures
Political
US Equities
Here's How Much You Would Have Made Owning Natera Stock In The Last 10 Years
June 13, 2025
Via
Benzinga
A Look Back at Immuno-Oncology Stocks’ Q1 Earnings: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Pack
June 11, 2025
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase
June 10, 2025
Genetic testing company Natera (NASDAQ:NTRA). reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 36.5% year on year to $501.8 million. The company’s full-year revenue...
Via
StockStory
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
Preview: Natera's Earnings
May 07, 2025
Via
Benzinga
Peering Into Natera's Recent Short Interest
May 02, 2025
Via
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
June 04, 2025
Via
Benzinga
2 Cash-Heavy Stocks for Long-Term Investors and 1 to Be Wary Of
June 02, 2025
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...
Via
StockStory
3 Mid-Cap Stocks Worth Your Attention
May 27, 2025
Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulatory leadership, but a few mid-sized businesses...
Via
StockStory
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
May 26, 2025
Via
Benzinga
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
May 12, 2025
Via
Benzinga
8 Analysts Have This To Say About Natera
May 09, 2025
Via
Benzinga
Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales
May 08, 2025
Genetic testing company Natera (NASDAQ:NTRA). announced better-than-expected revenue in Q1 CY2025, with sales up 36.5% year on year to $501.8 million. The company’s full-year revenue guidance of $1.98...
Via
StockStory
What To Expect From Natera’s (NTRA) Q1 Earnings
May 07, 2025
Genetic testing company Natera (NASDAQ:NTRA). will be reporting earnings tomorrow after market hours. Here’s what you need to know.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of
April 29, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...
Via
StockStory
Topics
Stocks
Exposures
COVID-19
US Equities
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
April 28, 2025
Via
Benzinga
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Turn Down
April 18, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...
Via
StockStory
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
April 17, 2025
Via
Benzinga
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
April 17, 2025
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Via
Investor's Business Daily
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
April 15, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
April 14, 2025
Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron (NASDAQ:REGN) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Assessing Natera: Insights From 10 Financial Analysts
April 10, 2025
Via
Benzinga
3 Reasons NTRA Has Explosive Upside Potential
April 08, 2025
Natera currently trades at $141.03 and has been a dream stock for shareholders. It’s returned 351% since April 2020, blowing past the S&P 500’s 87.1% gain. The company has also beaten the index over...
Via
StockStory
Topics
Government
Stocks
Exposures
Political
US Equities
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
April 07, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
April 07, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Incyte (NASDAQ:INCY) and the best and worst...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is the Market Bullish or Bearish on Natera?
April 04, 2025
Via
Benzinga
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
March 20, 2025
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the immuno-oncology stocks, including Natera (NASDAQ:NTRA) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
March 19, 2025
Via
The Motley Fool
1 Mid-Cap Stock to Own for Decades and 2 to Brush Off
March 18, 2025
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.